NFE2L2 and amyotrophic lateral sclerosis: Indeed, Nrf2 activity can be further enhanced in astrocytes by genetic manipulation, which improves disease outcome in animal models of ALS (Vargas et al., 2008), PD (Chen et al., 2009; Gan et al., 2012), and HD (Calkins et al., 2010).